Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor
Information source: University of California, Irvine
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Dysfunctional Labor
Intervention: Propranolol (Drug)
Phase: Phase 2
Status: Recruiting
Sponsored by: University of California, Irvine Official(s) and/or principal investigator(s):
Leah R Battista, MD, Principal Investigator, Affiliation: University of California, Irvine
Overall contact:
Leah R Battista, MD, Phone: 714 456 5967, Email: lbattist@uci.edu
Summary
The purpose of this study is to determine whether propranolol is better than oxytocin for the
treatment of labor abnormalities. The endpoint is the rate of vaginal delivery experienced by
women receiving prolonged oxytocin versus propranolol.
Clinical Details
Official title: Placebo-Controlled Randomized Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Dysfunctional Labor
Study design: Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study
Primary outcome: Vaginal delivery ratesCesarean section rates
Secondary outcome: Number of dosesNeonatal outcomes Maternal safety
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- Must be term pregnancy (> 37 weeks)
- Vertex presentation
- Active labor (4-5 centimeters dilated)
Exclusion Criteria:
- Heart disease
- Diabetes
- Currently taking propranolol
- Contraindications to labor or vaginal delivery
- Multiple gestations
- Preterm
- Chorioamnionitis
Locations and Contacts
Leah R Battista, MD, Phone: 714 456 5967, Email: lbattist@uci.edu
Long Beach Memorial Medical Center, Long Beach, California, United States; Recruiting
Additional Information
Starting date: January 2004
Last updated: April 19, 2006
|
